VTGN - Vistagen reports positive results for mental fatigue treatment
2024-04-25 14:16:08 ET
More on VistaGen Therapeutics
- Vistagen Therapeutics: A Pipeline With Potential In Anxiety And Depression
- Vistagen Therapeutics: Initial Analysis Of Fasedienol Points To Bullish
- Why VistaGen Therapeutics Is A Buy: Fasedienol Potential For Anxiety Treatments
- Seeking Alpha’s Quant Rating on VistaGen Therapeutics
- Historical earnings data for VistaGen Therapeutics